Effect of minor tranquilizers, tryptamine antagonists and amphetamine on behavior punished by brain stimulation.
Earlier observations have shown that septal lesions released operant responding punished by foot-shock, but did not change behavior punished by electrical stimulation of the dorsal periaqueductal gray (DPAG) substance of the rat brain. In contrast, chlordiazepoxide facilitated both kinds of punished responding. In order to further study the mechanism of brain stimulation punishment, dose-response curves of two minor tranquilizers, chlordiazepoxide and pentobarbital, of two tryptamine antagonists, methysergide and cyproheptadine as well as of amphetamine on lever-pressing behavior of rats maintained by water reinforcement and punished by DPAG stimulation were determined. A multiple schedule with a variable-interval 2 min (VI 2) non-punished component and a continuous reinforcement (CRF) component in which every response was both rewarded and punished was used. Chlordiazepoxide and pentobarbital caused dose-dependent increases in punished responding. Unpunished VI response rates were also moderately increased by the minor tranquilizers. In contrast, neither methysergide nor cyproheptadine increased punished or unpunished responding at doses that have been previously shown to markedly release behavior punished by foot-shock, in the rat. Conversely, amphetamine, a drug that usually does not release responding punished by peripheral noxious stimulation, caused dose-dependent increases in responding suppressed by DPAG punishment without affecting VI response rate. These and previous results with septal lesions suggest that neither the septo-hippocampal system nor its serotonergic input from the mesencephalon mediate response suppression by DPAG electrical stimulation, in contrast to their active role in peripheral punishment. This difference may also explain the marked facilitatory effect of amphetamine on responding punished by brain stimulation shown by the present results.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects* / Q000502:physiology; D001921:Brain / Q000502:physiology; D002707:Chlordiazepoxide / Q000494:pharmacology; D003216:Conditioning, Operant; D003533:Cyproheptadine / Q000494:pharmacology; D004597:Electroshock; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D011678:Punishment; D051381:Rats; D014363:Tryptamines / Q000037:antagonists & inhibitors*
D014151:Anti-Anxiety Agents; D014363:Tryptamines; D003533:Cyproheptadine; D002707:Chlordiazepoxide; D000661:Amphetamine; D010424:Pentobarbital; D008784:Methysergide